Se trata de uno de los primeros grupos multidisciplinares de España especializados en esta enfermedad minoritaria sistémica, que puede provocar un gran número de síntomas
Read moreLa propuesta de revisión de la legislación farmacéutica europea publicada este miércoles por la Comisión Europea contiene una serie de medidas que ponen en riesgo el futuro de la industria farmac...
Read moreSon muchos son los cambios que se han producido en la regulación de la experimentación animal, y los avances en la búsqueda y validación de modelos alternativos, lo que confirma que estamos en un ...
Read moreA study by the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona (UB) with the Arctic University of Norway compares the effect of two treatments on the alterations in m...
Read moreThe project evaluates the feasibility of implementing LOLA, an AI-based virtual medical assistant with conversational technology that provides personalized tracking to patients suffering from heart fa...
Read moreResearch conducted in Lleida has discovered a new link between intracellular calcium, signalling pathways and autophagy that represents a new advance in preventing alterations in the process of cell d...
Read moreAn international consortium aims to address this challenge by developing the new PLAST_CELL technology platform that can quantitatively assess tumor plasticity at the single cell level.
Read moreThe Neurological Tissue Bank (NTB) of the Biobank at IDIBAPS-Hospital Clínic Barcelona has received 2,300 nervous tissue donations. Nervous tissue samples are essential for research into neurological...
Read moreThe pioneering artificial cornea designed and generated from biomaterials and stem cells by scientists from Granada has successfully passed its first clinical trial in humans, and has made it possible...
Read moreElectronic inhaler monitoring devices can significantly improve patient adherence to inhaled therapy in adults with asthma or chronic obstructive pulmonary disease (COPD)
Read moreUn estudio europeo muestra que España ha pasado de un 53% a un 58% de accesibilidad a los fármacos que aprueba la EMA, frente al 88% de Alemania o el 80% de Italia
Read moreAbyntek Biopharma, through its Corporate Social Responsibility program "We finance your project", materializes its commitment to oncology research by allocating resources to finance and facilitate the...
Read more